Parametric Portfolio Associates’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $2.73M | Sell |
82,347
-22,711
| -22% | -$754K | ﹤0.01% | 2250 |
|
|
2021
Q4 | $3.44M | Buy |
105,058
+25,233
| +32% | +$825K | ﹤0.01% | 2107 |
|
|
2021
Q3 | $3.35M | Buy |
79,825
+6,307
| +9% | +$264K | ﹤0.01% | 2109 |
|
|
2021
Q2 | $2.86M | Buy |
73,518
+17,063
| +30% | +$663K | ﹤0.01% | 2217 |
|
|
2021
Q1 | $1.93M | Buy |
56,455
+11,749
| +26% | +$401K | ﹤0.01% | 2801 |
|
|
2020
Q4 | $2.03M | Buy |
44,706
+21,667
| +94% | +$983K | ﹤0.01% | 2640 |
|
|
2020
Q3 | $634K | Sell |
23,039
-25,341
| -52% | -$697K | ﹤0.01% | 3157 |
|
|
2020
Q2 | $1.78M | Buy |
48,380
+15,901
| +49% | +$586K | ﹤0.01% | 2566 |
|
|
2020
Q1 | $1.05M | Sell |
32,479
-8,433
| -21% | -$273K | ﹤0.01% | 2768 |
|
|
2019
Q4 | $1.68M | Buy |
40,912
+20,704
| +102% | +$848K | ﹤0.01% | 2800 |
|
|
2019
Q3 | $719K | Sell |
20,208
-8,261
| -29% | -$294K | ﹤0.01% | 3198 |
|
|
2019
Q2 | $1.46M | Sell |
28,469
-17,903
| -39% | -$919K | ﹤0.01% | 2850 |
|
|
2019
Q1 | $2.66M | Buy |
46,372
+18,806
| +68% | +$1.08M | ﹤0.01% | 2477 |
|
|
2018
Q4 | $1.16M | Sell |
27,566
-651
| -2% | -$27.3K | ﹤0.01% | 2891 |
|
|
2018
Q3 | $2.13M | Sell |
28,217
-14,925
| -35% | -$1.13M | ﹤0.01% | 2668 |
|
|
2018
Q2 | $3.1M | Buy |
+43,142
| New | +$3.1M | ﹤0.01% | 2356 |
|
|
2017
Q3 | – | Sell |
-40,935
| Closed | -$808K | – | 4047 |
|
|
2017
Q2 | $808K | Buy |
40,935
+7
| +0% | +$138 | ﹤0.01% | 3097 |
|
|
2017
Q1 | $790K | Buy |
40,928
+25,729
| +169% | +$497K | ﹤0.01% | 2979 |
|
|
2016
Q4 | $282K | Buy |
+15,199
| New | +$282K | ﹤0.01% | 3449 |
|